Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated

Leukemia

Volumn 10, Issue 5, 1996, Pages 854-859

  Taylor, G M ^a   Gokhale, D A ^a   Crowther, D ^b   Woll, P ^b   Harris, M ^b   Alexander, F ^c   Jarrett, R ^d   Cartwright, R A ^e  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Genetic susceptibility; HLA DPB1; Hodgkin's disease

Indexed keywords

HLA DP ANTIGEN;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HLA TYPING; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOGENETICS; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029937555     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cole P, MacMahon B, Aisenberg A. Mortality from Hodgkin's disease in the United States. Evidence for the multiple-aetiology hypothesis. Lancet 1968; II: 1371-1376.
2. Vianna NJ, Greenwald P, Davies JNP. Nature of Hodgkin's disease agent. Lancet 1971; I: 733-736.
3. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. New Engl J Med 1981; 304: 135-140.
4. Alexander FE, Ricketts TJ, McKinney PA, Cartwright RA. Community lifestyle characteristics and incidence of Hodgkin's disease in young people, Int J Cancer 1991; 48: 10-14.
5. Claser SL. Black-white differences in Hodgkin's disease incidence in the United States by age, sex, histology subtype and time, Int J Epidemiol 1991; 20: 68-75.
6. Weiss LM, Movahed LA, Warnke RA, SklarJ. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. New Engl J Med 1989; 320: 502-506.
7. Wu T-C, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease, Int J Cancer 1990; 46: 801-804.
8. Khan C, Coates PJ, Gupta RK, Kangro HO, Slavin C. Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. Am J Pathol 1992; 140: 757-762.
9. Jarrett RF, Callagher A, Jones DB, Alexander FE, Krajewski AS, Kelsey A, Adams J, Angus B, Gledhill S, Wright DH, Cartwright RA, Onions DE. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol 1991; 44: 844-848.
10. Hill AVS, Allsopp CEM, Kwiatowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwod BM. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600.
11. Amiel JL. Study of the leukocyte phenotypes in Hodgkin's disease. In: Curtoni ES, Mattiuz PL, Tosi RM (eds). Histocompatibility Testing. Munksgaard: Copenhagen, 1967, p 79.
12. Hors J, Dausset J. HLA and susceptibility to Hodgkin's disease. Immunol Rev 1983; 70: 167-192.
13. Bodmer JG, Tonks S, Oza AM, Lister TA, Bodmer WF. HLA-DP based resistance to Hodgkin's disease. Lancet 1989; 1: 1455-1456.
14. Bodmer JG, Tonks S, Oza AM, Mikata A, Takenouchi T, Lister TA et al. Hodgkin's disease study. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991. Oxford University Press: Oxford 1992, pp 701-709.
15. Tonks S, Oza AM, Lister TA, Bodmer JG. Association of HLA-DPB with Hodgkin's disease. Lancet 1992; 340: 968-969.
16. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P. Report of the nomenclature committee. Cancer Res 1966; 26: 1311.
17. Bugawan TL, Horn GT, Long CM, Mickelson E, Hansen JA, Ferrara GB, Angelini G, Erlich HA. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-α and DP-β loci. J Immunol 1988; 141: 4024-4030.
18. Bugawan TL, Begovich AB, Erlich HA. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes, Immunogenetics 1990; 32: 231-241.
19. Tait BD, Bodmer JG, Erlich HA, Ferrara GB, Albert E, Begovich A, Kimura A, Varney MD, Klitz W. DNA typing: DPA and DPB analysis. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991. Oxford University Press: Oxford, 1992, pp 485-496.
20. Levitan M. Textbook of Human Genetics, 3rd edn. Oxford University Press: New York, 1988.
21. Brown JH, Jardetsky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 1988; 332: 845-850.
22. Brown JH, Jardestsky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364: 33-39.
23. Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB. Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet 1994; 54: 497-505.
24. Chicz RM, Urban RG, Gorga JC, Vignalli DAA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27-47.
25. Moonsamy PV, Suraj VC, Bugawan TL, Saiki RK, Stoneking M, Roudier J, Magzoub MMA, Hill AVS, Begovich AB. Genetic diversity within the HLA class II region: ten new DPB1 alleles and their population distribution. Tissue Antigens 1992; 40: 153-157.